Who cares about preventing acute respiratory distress syndrome?

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 3, 2015, Pages 255-260

  Rubenfeld, Gordon D ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CORTICOSTEROID; DIURETIC AGENT; METHYLPREDNISOLONE; NESIRITIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CATHETER INFECTION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COGNITION; CORTICOSTEROID THERAPY; COST CONTROL; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEART INFARCTION; HEART OUTPUT; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LONG TERM SURVIVAL; OXYGENATION; PATIENT COUNSELING; PATIENT SATISFACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PULSE OXIMETRY; QUALITY OF LIFE; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY; VENOUS THROMBOEMBOLISM; VENTILATOR ASSOCIATED PNEUMONIA; EVIDENCE BASED MEDICINE; MORTALITY; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; STANDARDS; UNITED STATES;

CRITICAL CARE; EVIDENCE-BASED MEDICINE; HOSPITAL MORTALITY; HUMANS; PHYSICIAN'S ROLE; QUALITY OF LIFE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; UNITED STATES;

EID: 84922311550     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201408-1574CP     Document Type: Review

References (61)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693.
2. Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008;133:1120-1127.
3. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009;179:220-227.
4. Duggal A, Ganapathy A, Mohana Ratnapalan M, Adhikari NK. Pharmacological treatments for acute respiratory distress syndrome: systematic review. Minerva Anestesiol (In press)
5. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson H III, Hoth JJ, Mikkelsen ME, Gentile NT, et al.; U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011;183: 462-470.
6. Clinical Centers for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network. May 15, 2013 [accessed 2014 Aug 20]. Available from: http://grants.nih.gov/grants/guide/rfafiles/RFA-HL-14-014.html
7. FY14 Peer Reviewed Medical Research Program Clinical Trial Award. 2014 [accessed 2014 Aug 20]. Available from: http://cdmrp.army.mil/funding/pa/14prmrpcta-pa.pdf
8. Kor DJ, Talmor DS, Banner-Goodspeed VM, Carter RE, Hinds R, Park PK, Gajic O, Gong MN; US Critical Illness and Injury Trials Group: Lung Injury Prevention with Aspirin Study Group (USCIITG: LIPS-A). Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open 2012;2:e001606.
9. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989;8:431-440.
10. Rubenfeld GD. Surrogate measures of patient-centered outcomes in critical care. In: Angus DC, Carlet J, editors. Surviving intensive care. Berlin: Springer-Verlag; 2002.
11. Rubenfeld GD, Abraham E. When is a negative phase II trial truly negative? Am J Respir Crit Care Med 2008;178:554-555.
12. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-788.
13. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233.
14. Psaty BM, Lumley T. Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs. JAMA 2008;299:1474-1476.
15. Schatzkin A, Gail M. The promise and peril of surrogate end points in cancer research. Nat Rev Cancer 2002;2:19-27.
16. López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
17. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al.; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-124.
18. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510-524.
19. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011;365:32-43. [Published erratum appears in N Engl J Med 365:773. Wilson WH corrected to Tang WHW.]
20. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-1905.
21. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007;334:779.
22. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
23. Treggiari MM, Hudson LD, Martin DP, Weiss NS, Caldwell E, Rubenfeld G. Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med 2004;32: 327-331.
24. Shah CV, Localio AR, Lanken PN, Kahn JM, Bellamy S, Gallop R, Finkel B, Gracias VH, Fuchs BD, Christie JD. The impact of development of acute lung injury on hospital mortality in critically ill trauma patients. Crit Care Med 2008;36:2309-2315.
25. Mikkelsen ME, Shah CV, Meyer NJ, Gaieski DF, Lyon S, Miltiades AN, Goyal M, Fuchs BD, Bellamy SL, Christie JD. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock 2013;40:375-381.
26. Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999; 281:354-360.
27. Stapleton RD, Wang BM, Hudson LD, Rubenfeld GD, Caldwell ES, Steinberg KP. Causes and timing of death in patients with ARDS. Chest 2005;128:525-532.
28. Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, Bonde J; The ARF Study Group. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 1999; 159:1849-1861.
29. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010;304:1787-1794.
30. Davidson TA, Rubenfeld GD, Caldwell ES, Hudson LD, Steinberg KP. The effect of acute respiratory distress syndrome on long-term survival. Am J Respir Crit Care Med 1999;160:1838-1842.
31. Cooke CR. Economics of mechanical ventilation and respiratory failure. Crit Care Clin 2012;28:39-55 (vi.).
32. Krag M, Perner A, Wetterslev J, Wise MP, Hylander Møller M. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: a systematic review of randomised clinical trials with metaanalysis and trial sequential analysis. Intensive Care Med 2014;40: 11-22.
33. Dodek P, Keenan S, Cook D, Heyland D, Jacka M, Hand L, Muscedere J, Foster D, Mehta N, Hall R, et al.; Canadian Critical Care Trials Group; Canadian Critical Care Society. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004;141:305-313.
34. Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 2013;41:2088-2098.
35. Blot K, Bergs J, Vogelaers D, Blot S, Vandijck D. Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis 2014;59:96-105.
36. M͡oz A, Mongilardi N, Checkley W. Multilevel competing risks in the evaluation of nosocomial infections: time to move on from proportional hazards and even from hazards altogether. Crit Care 2014;18:146.
37. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vé sin A, Garrouste-Orgeas M, Decruyenaere J, Clec 'h C, Azoulay E, Benoit D; Outcomerea Study Group. Attributable mortality of ventilatorassociated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011;184:1133-1139.
38. Melsen WG, Rovers MM, Koeman M, Bonten MJ. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med 2011;39:2736-2742.
39. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, et al.; NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008;300:805-813.
40. Browner WS, Newman TB. Are all signi ficant P values created equal? The analogy between diagnostic tests and clinical research. JAMA 1987;257:2459-2463.
41. Christley RM. Power and error: increased risk of false positive results in underpowered studies. Open Epidemiol J 2010;3:16-19.
42. Cook DJ, Grif fith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, Kirby A, Tryba M; Canadian Critical Care Trials Group. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5:368-375.
43. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acidsuppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 2011;183:310-319.
44. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170: 784-790.
45. Fujii S, Tanimukai H, Kashiwagi Y. Comparison and analysis of delirium induced by histamine h(2) receptor antagonists and proton pump inhibitors in cancer patients. Case Rep Oncol 2012;5:409-412.
46. Kahn JM, Doctor JN, Rubenfeld GD. Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Med 2006;32: 1151-1158.
47. Chiasson TC, Manns BJ, Stelfox HT. An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med 2009;6:e1000098.
48. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354: 2564-2575.
49. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-1684.
50. Mikkelsen ME, Christie JD, Lanken PN, Biester RC, Thompson BT, Bellamy SL, Localio AR, Demissie E, Hopkins RO, Angus DC. The adult respiratory distress syndrome cognitive outcomes study: longterm neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med 2012;185:1307-1315.
51. US Preventive Services Task Force (USPSTF). Estimating certainty and magnitude of net benefit. 2007 [accessed 2014 Aug 28]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf07/methods/benefit.htm
52. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:396-404.
53. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000; 320:1380-1384.
54. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370: 2083-2092.
55. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38:1573-1582.
56. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDSDefinition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
57. Schultz MJ, de Jonge E, Kesecioglu J. Selective decontamination of the digestive tract reduces mortality in critically ill patients. Crit Care 2003;7:107-110.
58. Langevin PB, Hellein V, Harms SM, Tharp WK, Cheung-Seekit C, Lampotang S. Synchronization of radiograph film exposure with the inspiratory pause: effect on the appearance of bedside chest radiographs in mechanically ventilated patients. Am J Respir Crit Care Med 1999;160:2067-2071.
59. Goldstein RS, Young J, Rebuck AS. Effect of breathing pattern on oxygen concentration received from standard face masks. Lancet 1982;2:1188-1190.
60. O2 ratio in patients with acute lung injury or ARDS. Chest 2007;132:410-417.
61. Levitt JE, Matthay MA. Clinical review: early treatment of acute lung injury - paradigm shift toward prevention and treatment prior to respiratory failure. Crit Care 2012;16:223.